Chronic obstructive pulmonary disease (COPD) is a frequent comorbid condition associated
with increased morbidity and mortality. Pneumonia is the most common infectious disease …

Rationale: Radiographically confirmed pneumonia risk with inhaled corticosteroid use in
chronic obstructive pulmonary disease (COPD) has not been assessed to date. Objectives …

Chronic obstructive pulmonary disease (COPD) is a major public health problem in India.
Although several International guidelines for diagnosis and management of COPD are …

Background Pseudomonas aeruginosa is not a frequent pathogen in community-acquired
pneumonia (CAP). However, in patients with severe CAP, P aeruginosa can be the etiology …

Pulmonary disease prevalence increases with age and contributes to morbidity and mortality
in older patients. Dyspnea in older patients is often ascribed to multiple etiologies such as …

Background The use of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease (COPD) has been associated with an increased risk of pneumonia in …

ABSTRACT RATIONALE: Since the last published Canadian Thoracic Society (CTS) COPD
guideline in 2007 and the 2008 update–highlights for primary care, many new clinical trials …

Chronic respiratory diseases are among the leading causes of mortality worldwide, with the
major contributor, chronic obstructive pulmonary disease (COPD) accounting for …

Inhaled corticosteroids are widely used in chronic obstructive pulmonary disease (COPD)
and, in combination with long-acting β 2 agonists, reduce exacerbations and improve lung …

Chronic obstructive pulmonary disease (COPD) is an important lung disease characterized
by complicated symptoms including emphysema. We aimed to explore the mechanisms …